Drug Profile
TAK 259
Alternative Names: TAK-259Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Takeda
- Class
- Mechanism of Action Alpha 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Overactive bladder
Most Recent Events
- 04 Feb 2013 Discontinued - Phase-I for Overactive bladder in Japan (PO)
- 29 Jul 2011 Phase-I clinical trials in Overactive bladder in Japan (PO)